Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Amanta Healthcare Ltd.
₹108.50
₹102.00
₹108.90
₹92.00
₹154.40
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 74.49 | 70.89 | 65.31 | 72.06 | 67.81 |
| Operating Expense | 59.13 | 56.24 | 50.41 | 53.10 | 54.39 |
| Operating Profit | 15.36 | 14.65 | 14.89 | 18.96 | 13.43 |
| Depreciation | 4.67 | 4.66 | 4.64 | 4.69 | 4.51 |
| Interest | 5.06 | 5.15 | 6.29 | 6.28 | 5.90 |
| Tax | 1.67 | 1.07 | 1.42 | 2.19 | 1.25 |
| Net Profit | 4.63 | 1.21 | 3.51 | 5.96 | 2.65 |
₹108.50
↗ Bullish Moving Average
12
↘ Bearish Moving Average
1
| Held By | Sep 2025 | Dec 2025 |
|---|---|---|
| Promoter | 63.6 | 63.6 |
| FII | 1 | 1.1 |
| DII | 11.3 | 11.2 |
| Public | 24.1 | 24.1 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 75.06 K | 1.17 L | 64.42% |
| Week | 72.49 K | 1.11 L | 65.54% |
| 1 Month | 95.33 K | 1.31 L | 72.63% |
| 6 Month | 62.32 K | 97.5 K | 63.92% |
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
High Volume, High Gain
Top Gainers
High Volume, High Gain
Volume Shockers
Insiders bought stocks
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹5.80 | ₹89.80 | ₹112.60 | ₹17.20 | ₹214 |
| % Change | 4.88% | -10.11% | -0.42% | 0.00% | 0.19% |
| Revenue TTM (₹ Cr) | ₹83.60 | - | - | - | - |
| Net Profit TTM (₹ Cr) | ₹-34.95 | - | - | - | - |
| PE TTM | -1.40 | 11.90 | - | 5.90 | 37.30 |
| 1 Year Return | 479 | -29.73 | 24.34 | -60 | 124.27 |
| ROCE | -5.63 | - | - | - | - |
Ind-Swift Laboratories Ltd.
₹ 139.00
+0.60%
Lincoln Pharmaceuticals Ltd.
₹ 614.40
+3.29%
Panacea Biotec Ltd.
₹ 321.95
-1.03%
Medicamen Biotech Ltd.
₹ 229.35
-0.99%
Themis Medicare Ltd.
₹ 79.37
+7.00%
Venus Remedies Ltd.
₹ 904.10
+5.00%
Bal Pharma Ltd.
₹ 64.56
-0.48%
Hikal Ltd.
₹ 160.01
+0.03%
NGL Fine - Chem Ltd.
₹ 2110.00
+1.38%
Hester Biosciences Ltd.
₹ 1405.00
+2.89%
Natural Capsules Ltd.
₹ 154.90
+0.83%
Krebs Biochemicals & Industries Ltd.
₹ 47.67
+7.27%
Kilitch Drugs(I) Ltd.
₹ 139.00
+0.47%
Syncom Formulation (India) Ltd.
₹ 11.50
+2.95%
Aarey Drugs & Pharmaceuticals Ltd.
₹ 53.70
+0.79%
Biofil Chemicals & Pharmaceuticals Ltd.
₹ 27.80
+0.91%
Aarti Drugs Ltd.
₹ 354.45
+2.32%
Wanbury Ltd.
₹ 231.95
+0.66%
Orchid Pharma Ltd.
₹ 523.80
+0.87%
Kopran Ltd.
₹ 120.00
+1.01%
IOL Chemicals and Pharmaceuticals Ltd.
₹ 77.20
-0.30%
Albert David Ltd.
₹ 662.00
+7.43%
Gufic BioSciences Ltd.
₹ 290.00
+0.45%
Jagsonpal Pharmaceuticals Ltd.
₹ 186.50
+0.45%
By signing up I certify terms, conditions & privacy policy